Abstract
Purpose
The research is endeavored to establish a serum protein fingerprint model for predicting radiosensitivity of nasopharyngeal carcinoma through the analysis of the serum expressed proteins of the pre- and post-treatment nasopharyngeal carcinoma patients treated with radiotherapy.
Methods
Surface-enhanced laser desorption ionization-time of flight-mass spectrometry and CM-10 protein chip were used to detect the serum proteomic patterns of 50 nasopharyngeal carcinoma patients with different radiosensitivity. Thirty-eight of the 50 patients after the treatment were also studied. Biomarker Wizard 3.01 and Biomarker Pattern 5.01 were used in combination to analyze the data and to develop predicting models.
Results
At the molecular weight range of 2,000–20,000, the software identified an average of 83 mass peaks between radiation sensitive group and radiation resistant group. 11 protein peaks were significantly different. Of the 83 mass peaks, 4 mass peaks (mass/charge ratio [m/z] 2,575, 3,942, 6,117 and 6,778) were chosen automatically to construct a classification tree. The diagnostic accuracy was 78.0 %. M/z 6,117 and 6,778 of the radiation sensitive group after the treatment trended to those of the radiation resistant group.
Conclusions
The technology of surface-enhanced laser desorption ionization-time of flight-mass spectrometry can be used to screen and identify differentially expressed proteins associated with different radiosensitivity in nasopharyngeal cancer. It should be a very useful tool for predicting radiosensitivity of nasopharyngeal carcinoma.
Similar content being viewed by others
References
Zhao C, Lu TX, Han F, Lu LX, Huang SM, Deng XW, et al. Clinical study of 139 nasopharyngeal carcinoma patients for intensity modulated radiation therapy. Chin J Radiat Oncol. 2006;15(1):1–6.
Wang XS, Hu CS, Wu YR, Feng Y. Influence of speed in tumor regression on prognosis of nasopharyngeal carcinoma. Chin J Radiat Oncol. 2005;14(1):6–9.
Wang Q, Li L, Li DR, Zhang W, Wei X, Zhang JQ, et al. Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology. Chin J Obstet Gynecol. 2006;41(8):544–8.
Sun W, He F. Applications of proteomics in hepatic diseases research. Sci China C Life Sci. 2004;47(2):101–6.
Mian S, Ball G, Hornbuckle J, Holding F, Carmichael J, Ellis I, et al. A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to paclitaxel and doxorubicin under in vitro conditions. Proteomics. 2003;3(9):1725–37.
Hayashida Y, Honda K, Osaka Y, Hara T, Umaki T, Tsuchida A, et al. Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling. Clin Cancer Res. 2005;11(22):8042–7.
Cho WC, Yip TT, Ngan RK, Podust VN, Yip C, Yiu HH, et al. ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin Chem. 2007;53(2):241–50.
Guan X, Li DR, Wang Q, Li L, Yun H, Zhang W. Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology. Chin J Cancer. 2008;11:1155–60.
Russo SM, Tepper JE, Baldwin AS Jr, Liu R, Adams J, Elliott P, et al. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys. 2001;50(1):183–93.
Rodel C, Haas J, Groth A, Grabenbauer GG, Sauer R, Rodel F. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys. 2003;55(5):1341–7.
Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF 3rd, et al. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg. 2007;245(2):259–66.
Acknowledgments
The work was sponsored by the clinical research special foundation of Wu Jieping medical foundation (No. 320.6750.06080), Guangxi scientific research and technology development Project (No. 0719006-2-23), Guangxi graduate education and innovation project (No. 2007105981002 M33), supplementary programs of Guangxi large instruments shared network test (No. 533-2007-112) (No. 555-2007-134), major research projects of Guangxi universities (No. 201101ZD004), and the key project of Guangxi heath care (No. 2011076).
Conflict of interest
The authors have declared that no competing interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Su, F., Zhu, X., Liang, Z. et al. Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity. Clin Transl Oncol 16, 147–152 (2014). https://doi.org/10.1007/s12094-013-1052-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-013-1052-y